Silver Santé Study experts from several institutions and countries are preparing to present their work at this year’s prestigious Alzheimer’s Association International Conference (AAIC).

The conference, which will take place this year online, is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease.

Silver Santé Study researchers, including those from the University of Caen, Inserm, and Hospices Civils De Lyon  in France, UCL in the UK, DZNE in Germany,  the University of Geneva in Switzerland and the University of  Liége in Belgium will be participating..

Project Coordinator, Dr Gaël Chételat, who will be among those attending the conference, says: “As the world’s leading Alzheimer’s conference, the AAIC provides an invaluable opportunity for us to share our findings with the international scientific community.

“We look forward to doing so and to hearing from other scientists about their most recent findings in this important field of research.”

The AAIC conference will take place online between the 27^th and 31^st July. For further info and to register visit https://www.alz.org/aaic/overview.asp

Dr Natalie Marchant, of UCL, presenting the key findings of the Silver Santé Study’s SCD Well trial at the AAIC Conference in 2019.